Successful Generation of Sperm Protein 17 (Sp17)-Specific Cytotoxic T Lymphocytes from Normal Donors: Implication for Tumour-Specific Adoptive Immunotherapy Following Allogeneic Stem Cell Transplantation for Sp17-Positive Multiple Myeloma-Reference-Cited by-同舟云学术

Successful Generation of Sperm Protein 17 (Sp17)-Specific Cytotoxic T Lymphocytes from Normal Donors: Implication for Tumour-Specific Adoptive Immunotherapy Following Allogeneic Stem Cell Transplantation for Sp17-Positive Multiple Myeloma

Published:2002-09-18 Issue:4 Volume:56 Page:429-433
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:

Author:

CHIRIVA-INTERNATI M.,WANG Z.,SALATI E.,WROBLEWSKI D.,LIM S. H.

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-3083.2002.01138.x/fullpdf

Reference15 articles.

1. Aschan J Lonnqvist B Ringd NO Kumlien G Gahrton G Graft-versus-myeloma effect Lancet 1996 346 8

2. Graft-versus-myeloma effect in two cases;Verdonck;Lancet,1996

3. Donor leukocyte infusion are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation;Lokhorst;Blood,1997

4. Sperm protein 17 (Sp17) is a novel cancer-testis (CT) antigen in multiple myeloma;Lim;Blood,2001

5. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk;Chiriva-Internati;Eur J Immunol,2001

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of new biomarkers in immune microenvironment of testicular germ cell tumour;Andrologia;2021-02-05

2. A novel method for efficient generation of antigen-specific effector T-cells using dendritic cells transduced with recombinant adeno-associated virus and p38 kinase blockade;Journal of Translational Medicine;2019-12

3. Preliminary report of a novel formulation of clinical-grade, fully matured, tumor-associated peptide-loaded dendritic cells for cancer immunotherapy;Translational Medicine Communications;2019-11-17

4. Immunotherapeutic interventions of Triple Negative Breast Cancer;Journal of Translational Medicine;2018-05-30

5. Development of a M cell‐targeted microparticulate platform, BSK02™, for oral immunization against the ovarian cancer antigen, sperm protein 17;Journal of Biomedical Materials Research Part B: Applied Biomaterials;2018-03-04